Title |
iPSC Reprogramming From Human Peripheral Blood Using Sendai Virus Mediated Gene Transfer |
Date Submitted |
April 26, 2012 |
Submitted by - |
Yang, Wenli |
Adapted from - |
UPenn iPSC Core and CHOP iPSC Core in-house protocols |
Contributors - |
1Yang, Wenli; 1Liu, Ying; 2Sullivan, Spencer; 2Mills, Jason |
Affiliation(s) - |
1University of Pennsylvania, 2Children’s Hospital of Philadelphia |
This protocol allows efficient generation of integration-free iPS cells from a small amount of peripheral blood (less than 1 ml). Peripheral blood mononuclear cells (PBMCs) are briefly cultured to expand the erythroblast (EB) population. They are then used to derive iPS cells using four recombinant Sendai viral vectors, expressing the four reprogramming factors Oct4, Sox2, Kfl4 and c-Myc.
Reagents | Supplier | Catalogue number |
---|---|---|
QBSF-60 |
Quality Biologicals |
160-204-101 |
Primocin |
Invivogen |
ant-pm-1 |
Pen/Strep |
Life Technologies |
15140-155 |
DMEM (high glucose) |
Life Technologies |
11965-118 |
Non-Essential Amino Acid (MEM-NEAA) |
Life Technologies |
11140-050 |
L-Glutamine |
Life Technologies |
25030-156 |
CytotuneTM- iPS Sendai Reprogramming kit |
|
A1378001 |
DMEM/F12 |
Life Technologies |
11330 |
2-Mercaptoetheranol |
Sigma |
M7522 -100ml |
b-FGF |
Life Technologies |
PHG0021 |
Knockout Serum Replacement (KOSR) |
Life Technologies |
10828 |
FBS |
Life Technologies |
16000-044 |
Define FBS |
Hyclone |
SH30070.01 |
MEF feeders |
Global Stem |
6001G |
0.1% geletin |
Millipore |
ES-006-B |
Recombinant human EPO (tissue culture grade) |
R&D Systems |
287-TC-500 |
Recombinant human IL-3, CF |
R&D Systems |
203-IL-010/CF |
Recombinant human IGF-1, CF |
R&D Systems |
291-G1-200 |
Recombinant human SCF, CF |
R&D Systems |
255-SC-010/CF |
Dexamethasone |
Sigma |
D8893-1MG |
L-Ascorbic Acid |
Sigma |
A4544-25G |
Expansion Medium (EM)* | Stock conc | Final Conc | Volume |
---|---|---|---|
QBSF-60 (serum free medium) |
|
|
10 mL |
(Antibiotics) |
|
|
|
Primocin |
500x |
100 µg /mL |
20 µL |
Pen/Strep |
100x |
1% |
100 µL |
Ascorbic Acid (AA) |
10 mg/mL |
50µg /mL |
50 µL |
(Growth factors) |
|
|
|
SCF |
50 µg/mL |
50 ng/mL |
10 µL |
IL-3 |
10 µg/mL |
10 ng/mL |
10 µL |
EPO |
2 U/µL |
2 U/mL |
10 µL |
IGF-1 |
100 µg/mL |
40 ng/mL |
4 µL |
Dexamethasone** |
1mM |
1µM |
10 µL |
*EM = QBSF (base media) + AA + growth factors
EM+P/S = QBSF (base media) + P/S + AA + growth factors
EM+Primocin = QBSF + primocin + AA + growth factors
**Keep dexamethasone and doxycycline protected from light (discard every 2 weeks)
MEF media (500 ml)
DMEM (high glucose): 450 ml
FBS: 50 ml
NEAA: 5 ml
L-glutamine
Pen/Strep: 5 ml
iPSC Media (500 ml)
DMEM/F12: 450 ml
Define FBS: 50 ml
NEAA: 5 ml
L-glutamine: 5ml
Pen/strep: 5 ml
2-mercaptoethonol: 3.5 µl
b-FGF: 10 ng/ml (50 µl of 100 µg/ml stock)
L-Ascorbic Acid: 50 µg/ml –add fresh 10mg/ml stock at each media change
hES Media (500 ml)
DMEM/F12: 400 ml
KOSR: 100 ml
NEAA: 5 ml
L-glutamine: 5ml
Pen/strep: 5 ml
2-mercaptoethonol: 3.5 µl
b-FGF: 10 ng/ml (50 µl of 100 ug/ml stock)
L-Ascorbic Acid: 50 µg/ml –add fresh 10mg/ml stock at each media change
D -9 to -12
Collect blood into BD Vacutainer 4 or 8 mL cell preparation tube (CPT) with sodium citrate1 or into EDTA or heparinized tubes and Ficoll extract PBMCs. Alternatively, thaw frozen PBMCs.
Fresh cells collected into CPT (8 ml)
Frozen cells
D-6 and D-3 (Pre-Transduction)
Switch media to EM (no antibiotics) at D-6 and collect spent media at D-3 for mycoplasma testing. Continue to culture in EM+P/S from D-3 on.
D-2 to D0 (FACS for Erythroblast markers)
D0 (Transduction)
4 Sendai viruses (CytoTuneTM) each expressing Oct3/4, Sox2, Klf4, c-Myc are used for transduction. We have found that 2.5x105 cells and 10 MOI of each virus gives >1% reprogramming efficiency. So less cells and/or lower MOI may be sufficient to generate enough colonies for picking.
D1 (Wash virus)
D2 Plate MEFs
D3 (Plate transduced cells)
D5…
~D9-12 (Small colonies emerge)
~D14-21 (Pick colonies)
Caption: Time course of iPSC generation
Support protocol: FACS analysis of erythroblast surface markers expression
Reagents | Supplier | Catalog Number |
---|---|---|
PE mouse IgG2a isotype control | BD | 555575 |
FITC mouse IgM isotype control | BD | 555584 |
PE mouse anti-human CD71 | BD | 561938 |
FITC mouse anti-human CD36 | BD | 561820 |
PBS | Life Technologies | 14190-136 |
Round bottom FACS tubes | BD | 352054 |
DMEM/F12 | Life Technologies | 11330 |
2-Mercaptoetheranol | Sigma | M7522 -100ml |
Staining Buffer: 10% FBS in PBS
Caption: Surface expression of two erythroblast markers CD36 and CD71. 90% of the cells should be positive for these markers before they can be used for reprogramming.
This page was last modified on October 18, 2012